Needle Free Drug Delivery Devices Market Growth, Analysis Report, Share, Trends and Overview 2023-2029

The global Needle Free Drug Delivery Devices Market is anticipated to grow at a considerable CAGR of 14.5% during the forecast period. The key players are developing and launching new devices and using new technology to deliver virtually painless injections, which is positively surging the demand of the market. For instance, in September 2021, Scientists developed a three-dimensional (3D) printed vaccine patch that provides greater protection than a typical immunization shot. The technique uses 3D-printed microneedles lined up on a polymer patch and barely long enough to reach the skin to deliver the vaccine. The ease and effectiveness of the new vaccine may lead to a new way to deliver vaccines that is painless, less invasive than a shot with a needle, and can be self-administered. The resulting immune response from the patch was 10 times greater than the vaccine delivered into an arm muscle with a needle jab.

A full report of Needle Free Drug Delivery Devices Market is available at: https://www.omrglobal.com/industry-reports/needle-free-drug-delivery-devices-market-size

Moreover, in October 2021, Dentapen is an innovative new way launched by Septodont to provide a pain-free injection experience for their patients. Septodont's Dentapen injection gives a constant flow, at the right place. This then allows the dentist time to focus more on needle insertion, leading to better control of the injection and a reduction in pain for the patient. Clinicians can hold it in two different ways - by the wings, like a manual syringe, or pen-like, for a precise injection during special procedures. Dentapen has reduced challenges such as Variations in pressure, which can damage tissue and cause discomfort to the patient, and Keeping the quality of injections consistent throughout the day.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/needle-free-drug-delivery-devices-market

Additionally, in October 2021, Researchers in the Netherlands are working together to develop laser technology to enable "virtually painless" injections without needles, which will ease fear and lower the threshold for vaccinations. The Bubble Gun is still a work in progress and could take 1-3 years before it is available to the general public. Bubble Gun uses a laser to push tiny droplets through the outer layer of the skin and the process is quicker than a mosquito bite and "should not cause pain", as nerve endings in the skin are not touched.

Market Coverage

• The market number available for - 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
o By Technology
o By Application
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- including GlaxoSmithKline PLC, Mika Medical Co., Novartis International AG, Pharma Jet, Inc., Portal Instruments, Inc., and others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Needle Free Drug Delivery Devices Market Report Segment

By Technology

• Inhaler Technology
• Jet Injectors
• Transdermal Patch Technology
• Other Technologies

By Application

• Pain Management
• Insulin Delivery
• Vaccine Delivery
• Pediatric Injections
• Others

Needle Free Drug Delivery Devices Market - Segment by Region

North America

• United States
• Canada

Europe

• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Middle East & Africa
• Latin America

Company Profiles

• 3M Co.
• Akra Dermojet
• Bespak
• Boerhinger Ingelheim International GmbH
• Crossject
• Enesi Pharma Ltd.
• Ferring Holding SA (Antares Pharma, Inc.)
• GlaxoSmithKline PLC
• Injex Pharma GmbH
• Inovio Pharmaceuticals, Inc.
• Mika Medical Co.
• Novartis AG
• Penjet Corp.
• PharmaJet, Inc.
• Portal Instruments

Reasons to Buying From us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

Visit More Report at

https://www.asiatimeskorea.com/press-release/nlp-%ec%8b%9c%ec%9e%a5-%eb%b3%b4%ea%b3%a0%ec%84%9c-2022-%ec%a3%bc%ec%9a%94-%ec%97%85%ec%b2%b4%eb%b3%84-%eb%8f%99%ed%96%a5-%ea%b7%9c%eb%aa%a8-%ea%b3%b5%ec%9c%a0-%eb%b0%8f-%ec%98%88%ec%b8%a1-2022-20/50926/

https://ictdaily.net/press-release/212085/nfv-%ec%9d%b8%ed%94%84%eb%9d%bc-%ec%8b%9c%ec%9e%a5-%eb%b3%b4%ea%b3%a0%ec%84%9c-2021-%ec%a3%bc%ec%9a%94-%ec%97%85%ec%b2%b4%eb%b3%84-%ea%b7%9c%eb%aa%a8-%ec%a0%90%ec%9c%a0%ec%9c%a8-%eb%b6%84%ec%84%9d/

https://jeunesexpress.ca/press-release/813867/part-de-marche-oss-et-bss-de-nouvelle-generation-2021-tendances-mondiales-acteurs-cles-analyse-de-lindustrie-et-rapport-2021-2027/

https://monblogapple.com/news/tendances-du-marche-du-sequencage-de-nouvelle-generation-rapport-de-recherche-croissance-opportunites-previsions-2022-2028/264621/

https://citytoday-hildesheim.de/news/397250/marktanteil-von-implantaten-der-naechsten-generation-2021-globale-trends-hauptakteure-branchenanalyse-und-bericht-2021-2027/

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.